KELSEY STURGIS: Open Payments
NPI 1306235569 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 92 payments from 24 companies in 2025. Trend: 2023 $1,899 · 2024 $2,227 · 2025 $1,728
Food & beverage: $1,728
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $200 |
| Novo Nordisk Inc | 10 | $184 |
| GlaxoSmithKline, LLC. | 10 | $171 |
| Sumitomo Pharma America, Inc. | 8 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $121 |
| Lilly USA, LLC | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Dexcom, Inc. | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Amgen Inc. | 4 | $64 |
Products named: JARDIANCE, GEMTESA, TRELEGY ELLIPTA, PREVNAR 20, Wegovy, NURTEC ODT, Dexcom G6 Transmitter, Kerendia.
Industry payments across MI — which companies pay providers there.
